Effect of 3,4-dihydroxyphenylalanine on Cu²⁺-induced Inactivation of HDL-associated Paraoxonase1 and Oxidation of HDL; Inactivation of Paraoxonase1 Activity Independent of HDL Lipid Oxidation

References

• La Du, B.N. (1996) "Structural and functional diversity of paraoxonase", Nat. Med. 2, 1186–1187.
   PubMed Web of Science ®Google Scholar
• Mackness, MI., Mackness, B., Durrington, P.A., Connelly, P.W. and Hegele, R.A. (1996) "Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins", Curr. Opin. Lipidol. 7, 69–76.
   PubMed Web of Science ®Google Scholar
• Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D. and Rosenblat, M. (2000) "Human serum paraoxnase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxi-dase-like activities", Circlulation 101, 2510–2517.
   PubMed Web of Science ®Google Scholar
• Shih, D.M., Cu, L., Hama, S., Xia, Y-R., Navab, M., Fogelman, A.M. and Lusis, A.J. (1996) "Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model", J. Clin. Investig. 97, 1630–1639.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Davies, G.K., Turkie, W., Lee, E., Roberts, D.H., Hill, E., Roberts, C., Durrington, P.N. and Mackness, MI. (2001) "Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?", Arterioscler. Thromb. Vasc. Biol. 21, 1451–1457.
   PubMed Web of Science ®Google Scholar
• Jarvik, G.P., Hatsukami, T.S., Carlson, C., Richter, R.J., Jampsa, R., Brophy, V.H., Margolin, S., Rieder, M., Nickerson, D., Schellenberg, G.D., Heagerty, P.J. and Furlong, C.E. (2003) "Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease", Arterioscler. Thromb. Vasc. Biol. 23, 1465–1471.
   PubMed Web of Science ®Google Scholar
• Jaouad, L., Milochevitch, C. and Khalil, A. (2003) "PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity", Free Radic. Res. 37, 77–83.
   PubMed Web of Science ®Google Scholar
• Nguyen, S.D. and Sok, D.E. (2003) "Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action", Free Radic. Res. 37(12), 1319–1330.
   Google Scholar
• Lovstad, R.A. (1984) "Catecholamine stimulation of copper dependent haemolysis: protective action of superoxide dismutase, catalase, hydroxyl radical scavengers and serum proteins (ceruloplasmin, albumin and apotransferrin)", Acta Pharmacol. Toxicol. (Copenh). 54(5), 340–345.
   Google Scholar
• Exner, M., Hermann, M., Hofbauer, R., Kapiotis, S. and Gmeiner, B.M. (2003) "Free and peptide-bound DOPA can inhibit initiation of low density lipoprotein oxidation", Free Radic. Res. 37(11), 1147–1156.
   Google Scholar
• Rogers, J.D., Sanchez-Saffon, A., Frol, A.B. and Diaz-Arrastia, R. (2003) "Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease", Arch. Neurol. 60(1), 59–64.
   Web of Science ®Google Scholar
• Nakaso, K., Yasui, K., Kowa, H., Kusumi, M., Ueda, K., Yoshimoto, Y, Takeshima, T., Sasaki, K. and Nakashima, K. (2003) "Hypertrophy of MC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype", J. Neurol. Sci. 207(1-2), 19–23.
   Web of Science ®Google Scholar
• Exner, M., Hermann, M., Hofbauer, R., Hartmann, B., Kapiotis, S. and Gmeiner, B. (2002) "Homocysteine promotes the LDL oxidase activity of ceruloplasmin", FEBS Lett. 531(3), 402–406.
   PubMed Web of Science ®Google Scholar
• Gan, K.N., Smolen, A., Eckerson, H.W. and La Du, B.N. (1991) "Purification of human serum paraoxonase/arylesterase", Drug Metab. Dispo. 19, 100–106.
   PubMed Web of Science ®Google Scholar
• Bub, A., Barth, S., Watzole, B., Briviba, K., Herbert, B.M., Luhrmann, P.M., Neuhauser-Berthold, M. and Rechkemmer, G. (2002) "Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid permddation in R-allele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet", Fur. J. Nutr. 41,237–243.
   Web of Science ®Google Scholar
• Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C.L., Newton, R.S. and La Du, B.N. (1999) "Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by anti-oxidants", Free Radic. Biol. Med. 26, 892–904.
   PubMed Web of Science ®Google Scholar
• Raveh, 0., Pinchuk, I., Fainaru, M. and Lichtenberg, D. (2001) "Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects", Free Radic. Biol. Med. 31, 1486–1497.
   PubMed Web of Science ®Google Scholar
• Wolff, ST. (1995) "Oxygen radicals in biological systems, Ferrous ion oxidation in presence of ferric ions indicator xylenol orange for measurment of hydroperoxides", Methods Enzymol. 233, 182–189.
   Google Scholar
• Halliwell, B., Gutteridge, J.M. and Aruoma, 0.1. (1987) "The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals", Anal. Biochem. 165, 215–219.
   Web of Science ®Google Scholar
• Stadtman, E.R. and Oliver, C.N. (1991) "Metal-catalyzed oxidation of proteins", J. Biol. Chem. 266, 2005–2008.
   PubMed Web of Science ®Google Scholar
• Nguyen, S.D. and Sok, D.E. (2003) "Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization", Biochem. J. 375, 275–285.
   PubMed Web of Science ®Google Scholar
• Martinelli, P., Contin, M., Scaglione, C., Riva, R., Albani, F. and Baruzzi, A. (2003) "Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?", Neurol. Sci. 24(3), 192–193.
   Google Scholar
• Black, K.J., Carl, J.L., Hartlein, J.M., Warren, S.L., Hershey, T. and Perlmutter, J.S. (2003) "Rapid intravenous loading of levodopa for human research: clinical results", J. Neurosci. Methods 127(1), 19–29.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman, B., Felix, C.C. and Sealy, R.C. (1984) "Peroxidatic oxidation of catecholamines: a kinetic electron spin resonance investigation using the spin stabilization approach", J. Biol. Chem. 259, 7584–7589.
   PubMed Web of Science ®Google Scholar
• Burkitt, M.A. (2001) "Critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and cerulo-plasmin", Arch. Biochem. Biophys. 394, 117–135.
   PubMed Web of Science ®Google Scholar
• Fu, S., Davies, M.J., Stocker, R. and Dean, R.T. (1998) "Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque", Biochem. J. 333,519–525.
   PubMed Web of Science ®Google Scholar
• Smith, C., Mitchinson, M.J., Aruoma, 0.1. and Halliwell, B. (1992) "Stimulation of lipid permddation and hydroxyl radical generation by the contents of human atherosclerotic lesions", Biochem. J. 286, 901–905.
   PubMed Web of Science ®Google Scholar
• Stadler, N., Lindner, R.A. and Davies, M.J. (2004) "Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper", Arterioscler. Thromb. Vasc. Biol. 24, 949–954.
   PubMed Web of Science ®Google Scholar
• Miller, J.W., Selhub, J., Nadeau, MR., Thomas, CA., Feldman, R.G. and Wolf, PA. (2003) "Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status", Neurology 60(7), 1125–1129.
   PubMed Web of Science ®Google Scholar
• Gieseg, ST., Pearson, J. and Firth, CA. (2003) "Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxy radical and macrophage-mediated oxidation", Free Radic. Res. 37, 983–991.
   PubMed Web of Science ®Google Scholar
• Hillstrom, R.J., Yacapin-Ammons, A.K. and Lynch, S.M. (2003) "Vitamin C inhibits lipid oxidation in human HDL", J. Nutr. 133(10), 3047–3051.
   PubMed Web of Science ®Google Scholar
• Nofer, J.R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G. and Von Eckardstein, A. (2002) "HDL and arteriosclerosis: beyond reverse cholesterol transport", Atherosclerosis 161(1), 1–16.
   PubMed Web of Science ®Google Scholar
• Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C. and La Du, B.N. (1998) "Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/ paraoxonase activities", Arterioscler. Thromb. Vasc. Biol. 18, 1617–1624.
   PubMed Web of Science ®Google Scholar
• Kunitake, ST., Jarvis, MR., Hamilton, R.L. and Kane, J.P. (1992) "Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins", Proc. Natl Acad. Sci. USA 89(15), 6993–6997.
   PubMed Web of Science ®Google Scholar
• Morin, B., Davies, M.J. and Dean, R.T. (1998) "The protein oxidation product 3,4-dihydroxyphenylalanine(ODOPA) mediates oxidative DNA damage", Biochem. J. 330, 1059–1067.
   PubMed Web of Science ®Google Scholar
• Bruce, D., Fu, S.L., Armstrong, S. and Dean, R.T. (1999) "Human apolipoprotein B from normal plasma contains oxidized peptides", Int. J. Biochem. Cell Biol. 31, 1409–1420.
   PubMed Web of Science ®Google Scholar